BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 1144891)

  • 1. [Comparison in changes in blood coagulation tests during use of oral contraceptives. First symposium - sexual steroids].
    Castillo JD; Mendoza C
    Rev Colomb Obstet Ginecol; 1975; 26(1):53-7. PubMed ID: 1144891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral contraceptives and blood coagulation.
    Bonnar J; Sabra AM
    J Reprod Med; 1986 Jun; 31(6 Suppl):551-6. PubMed ID: 2941571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased levels of activated factor VII and decreased plasma protein S activity and circulating thrombomodulin during use of oral contraceptives.
    Quehenberger P; Loner U; Kapiotis S; Handler S; Schneider B; Huber J; Speiser W
    Thromb Haemost; 1996 Nov; 76(5):729-34. PubMed ID: 8950781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood coagulation with a combination pill containing gestodene and ethinyl estradiol.
    Bonnar J; Daly L; Carroll E
    Int J Fertil; 1987; 32 Suppl():21-8. PubMed ID: 2906344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Action of hormonal contraceptives on the coagulation system and some of its inhibitors.
    Misz M; Beck P
    Acta Med Hung; 1986; 43(3):301-10. PubMed ID: 2438639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of two oral contraceptives, containing 30 or 20 microg of ethinyl estradiol in combination with gestodene, on blood coagulation and fibrinolysis in Brazilian women.
    Ferreira AC; Montes MB; Franceschini SA; Toloi MR
    Int J Fertil Womens Med; 2001; 46(5):265-70. PubMed ID: 11720199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term profile of a new progestin.
    Lippman J
    Int J Fertil; 1992; 37 Suppl 4():218-22. PubMed ID: 1362189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative studies of two oral contraceptives containing DL norgestrel and D norgestrel.
    Koetsawang S; Rimdusit S; Srivanaboon S; Bhiraleus P; Rachawat D
    J Med Assoc Thai; 1973 May; 56(5):314-8. PubMed ID: 4783789
    [No Abstract]   [Full Text] [Related]  

  • 9. [Evaluation of blood coagulation parameters after treatment with oral estro-progestational drugs].
    Sperandeo V; Ballo M; Martorana A
    Biol Lat; 1969; 22(2):117-25. PubMed ID: 5405780
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical trials of an association of norgestrel and ethinyl estradiol commercialized under the name of Stediril].
    Gaudefroy M; Corette L; Coliche D
    Bull Fed Soc Gynecol Obstet Lang Fr; 1971; 23(4):434. PubMed ID: 5153231
    [No Abstract]   [Full Text] [Related]  

  • 11. [Thrombelastography and oral contraceptives].
    Delacrétaz-Dubugnon F
    Schweiz Med Wochenschr; 1972 Jan; 102(2):48-52. PubMed ID: 4644685
    [No Abstract]   [Full Text] [Related]  

  • 12. Progestagens, blood-clotting, and blood-pressure.
    Lancet; 1977 Nov; 2(8047):1085-6. PubMed ID: 72996
    [No Abstract]   [Full Text] [Related]  

  • 13. Progestational agents and blood coagulation. VI. Relationship of ABO blood types to changes induced by oral contraceptives.
    Lillie MA; Mink IB
    Am J Obstet Gynecol; 1974 Jun; 119(3):406-10. PubMed ID: 4827381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Norgestimate: overview of a monophasic formulation.
    Anderson FD; Gillmer MD
    Int J Fertil Menopausal Stud; 1993; 38 Suppl 3():126-32. PubMed ID: 8260971
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical studies on the SH 1000 as oral contraception (author's transl)].
    Takayanagi M; Kamada M; Kushiki N; Lyo K; Fujiwara M
    Nihon Funin Gakkai Zasshi; 1974 Oct; 19(4):36-45. PubMed ID: 4478828
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical use of norgestrel-ethinyl oestradiol as a contraceptive.
    Tyler ET; Matsner EM; Gotlib MH; Levin M; Daniels T; Shimabukuro B; Dolman H; Elliot J
    J Reprod Fertil Suppl; 1968 Dec; 5():Suppl 5:109-16. PubMed ID: 5288229
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical experience with a new norgestimate-containing oral contraceptive.
    Huber J
    Int J Fertil; 1991; 36 Suppl 1():25-31. PubMed ID: 1678378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study of the behavior of hepatic function and blood coagulation in the course of oral administration of an estroprogestogen in low dosage].
    Pastore AR; Gaeta A; Police MA
    Riv Ital Ginecol; 1976; 57(3):171-85. PubMed ID: 1032427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of norgestrel in combination with ethinyl oestradiol on the human pituitary-adrenal axis.
    Givens JR; Fort AT; Leigh JH
    J Reprod Fertil Suppl; 1968 Dec; 5():Suppl 5:69-76. PubMed ID: 4330931
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of conventional or extended-cycle regimen of an oral contraceptive containing 30 mcg ethinylestradiol and 2 mg dienogest on various hemostasis parameters.
    Wiegratz I; Stahlberg S; Manthey T; Sänger N; Mittmann K; Lange E; Mellinger U; Kuhl H
    Contraception; 2008 Nov; 78(5):384-91. PubMed ID: 18929735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.